Higher pulse wave velocity seen in well-controlled diabetes

Higher pulse wave velocity seen in well-controlled diabetes
Pulse wave velocity is higher among patients with well-controlled type 2 diabetes when compared to controls, and is associated with white matter lesions, according to a study published online Nov. 5 in Diabetes Care.

(HealthDay)—Pulse wave velocity is higher among patients with well-controlled type 2 diabetes when compared to controls, and is associated with white matter lesions, according to a study published online Nov. 5 in Diabetes Care.

Esben Laugesen, M.D., from Aarhus University Hospital in Noerrebrogade, Denmark, and colleagues measured arterial stiffness with carotid-femoral pulse wave velocity and cerebral white matter lesions by (qualitatively graded by the Breteler scale) in 89 patients diagnosed with type 2 diabetes in the past five years and 89 matched controls. The authors note that arterial stiffness is associated with cardiovascular events and white matter lesions are associated with stroke.

The researchers found that the diabetes group had excellent glycemic control and had and lower total cholesterol than controls. However, even after adjusting for confounding variables, including age, sex, diabetes, , 24-hour mean arterial blood pressure, and medications, they had significantly higher carotid-femoral pulse wave velocity, which was significantly associated with Breteler score and cerebral white matter lesion volume.

"Pulse wave velocity was higher among patients with well-controlled type 2 diabetes compared with controls and was independently associated with white matter lesions," Laugesen and colleagues conclude. "Pulsed wave velocity may represent a clinically relevant parameter in the evaluation of cerebrovascular disease risk in type 2 diabetes."

The study was partially funded by research grants from the Foundation.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Metabolic syndrome linked to arterial stiffness in CKD

Jun 04, 2012

(HealthDay) -- For patients with chronic kidney disease (CKD), those with metabolic syndrome (MetS) have increased arterial stiffness but no increase in endothelial dysfunction, compared to those without MetS, ...

Recommended for you

Added fructose is a principal driver of type 2 diabetes

Jan 29, 2015

Recent studies have shown that added sugars, particularly those containing fructose, are a principal driver of diabetes and pre-diabetes, even more so than other carbohydrates. Clinical experts writing in Mayo Clinic Proceedings challe ...

Support found for peer-mentoring diabetes management program

Jan 29, 2015

Managing type 1 diabetes is a never-ending task that requires multiple blood glucose tests, carbohydrate calculations and insulin injections or infusions. This constant effort to control the disease is daunting at any age ...

How does DPP-4 inhibition affect liver function?

Jan 27, 2015

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.